{"schema_version":"secwatch.filing_event.v1","accession":"0001425450-23-000018","form_type":"8-K","ticker":"KIDS","cik":"0001425450","company_name":"ORTHOPEDIATRICS CORP","filed_at":"2023-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.892563+00:00","generated_at":"2026-06-18T21:44:03.818593+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"OrthoPediatrics Q4 revenue up 25% to $31M; guides FY2023 revenue $146-149M","bullets":["Q4 2022 revenue $31.0M (+25% YoY); FY2022 revenue $122.3M (+25% vs 2021).","GAAP net loss in Q4 $7.8M ($0.35/share) vs net income $0.1M in Q4 2021; FY2022 net income $1.3M ($0.06/share).","Adjusted EBITDA loss $2.2M in Q4 vs loss $0.6M a year ago; FY2022 adjusted EBITDA positive $0.2M.","Trauma & Deformity segment Q4 revenue $22.1M (+34% YoY); Scoliosis $8.0M (+12%); Sports Med/Other $0.9M (-22%).","International revenue grew 67% in Q4 and 47% for FY2022; cash $119.8M at Dec 31, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001425450-23-000018","json":"https://secwatch.observer/filing/0001425450-23-000018.json","markdown":"https://secwatch.observer/filing/0001425450-23-000018.md","text":"https://secwatch.observer/filing/0001425450-23-000018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1425450/000142545023000018/0001425450-23-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1425450/000142545023000018/kids-20230228.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T21:44:03.818593+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"20de52212e2180dd95c8110f3fdca91880591163","claim":"ORTHOPEDIATRICS CORP reported the fourth quarter and full year ended December 31, 2022 results: revenue $31.0 million. Guidance reaffirmed.","evidence_excerpt":"bringing the total to more than 630,000 since the inception of OrthoPediatrics when combined with MD Orthopaedics (\"MD Ortho\") and Pega Medical • Generated total revenue of $31.0 million for fourth quarter 2022, up 25% from $24.8 million in fourth quarter 2021; domestic revenue increased 15% and international revenue increased 67% in 2022 • Generated record total","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1425450/000142545023000018/0001425450-23-000018-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and full year ended December 31, 2022"},{"label":"Revenue","value":"$31.0 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}